How can I treat numbness?

Treatment of Numbness

The treatment of numbness depends entirely on the underlying cause, but for the two most common etiologies—diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy—first-line pharmacological management includes duloxetine (60-120 mg/day) or pregabalin (300-600 mg/day), as these are the only FDA-approved agents for neuropathic pain. 1

Identifying the Cause

The first critical step is determining what's causing the numbness:

• Diabetic peripheral neuropathy (DPN): Look for a stocking-glove distribution starting in fingers and toes, with numbness and tingling appearing before pain. This occurs in patients with diabetes and poor glycemic control. 1

• Chemotherapy-induced peripheral neuropathy (CIPN): Develops in patients receiving neurotoxic chemotherapy (particularly oxaliplatin or paclitaxel). Paclitaxel causes more prominent symptoms in lower extremities, while oxaliplatin affects upper extremities more during treatment. 1

• Carpal tunnel syndrome: Numbness specifically in the thumb, index finger, middle finger, and part of the ring finger, often with hand weakness. 2, 3

• Other causes: Spinal cord injury, nerve entrapment, or malignancy (particularly with isolated chin numbness). 4, 5, 6

Treatment Approach for Diabetic Peripheral Neuropathy

Metabolic Control (Foundation)

• Achieve tight glycemic control (HbA1c 6-7%) through lifestyle modification, diet, and exercise as the first step. 1
• Address cardiovascular risk factors including hypertension and hyperlipidemia. 1

First-Line Pharmacological Treatment

Duloxetine (Serotonin-Norepinephrine Reuptake Inhibitor)

• Dose: 60-120 mg/day 1
• Approximately 50% of patients achieve at least 50% pain reduction 1
• Number needed to treat (NNT): 4.9 for 120 mg/day, 5.2 for 60 mg/day 1
• Side effects are mild to moderate and transient: nausea, somnolence, dizziness, constipation, dry mouth 1
• Advantage: No weight gain and has antidepressant effects 1

Pregabalin (Anticonvulsant)

• Dose: 300-600 mg/day in divided doses 1
• NNT: 4.04 for 600 mg/day, 5.99 for 300 mg/day 1
• Side effects: dizziness, somnolence, peripheral edema, headache, weight gain 1

Second-Line Options

Tricyclic Antidepressants (TCAs)

• Amitriptyline or imipramine 25-75 mg/day 1
• Start at 10 mg/day in older patients, increase as needed 1
• NNT: 1.5-3.5 (though based on smaller trials) 1
• Critical warning: Doses >100 mg/day associated with increased risk of sudden cardiac death. Avoid in patients with cardiovascular disease or prolonged PR/QTc interval. 1

Gabapentin

• Dose: 900-3600 mg/day 1
• Well-established efficacy but requires high doses 1

Opioids (for refractory cases)

• Tramadol 200-400 mg/day, oxycodone 20-80 mg/day, or morphine sulfate sustained-release 20-80 mg/day 1

Topical Capsaicin Cream

• 0.075% applied sparingly 3-4 times daily 1

Treatment for Chemotherapy-Induced Peripheral Neuropathy

Important prognostic information:

• Paclitaxel-induced neuropathy improves over several months after chemotherapy completion 1
• Oxaliplatin-induced neuropathy worsens for 2-3 months after cessation (coasting phenomenon), then improves after approximately 3 months 1
• Hand symptoms improve faster than feet with oxaliplatin 1
• All pharmacological treatments are symptomatic only—none alter the natural history of nerve fiber loss 1

The same pharmacological agents used for diabetic neuropathy apply here, with duloxetine and pregabalin as first-line options.

Treatment for Carpal Tunnel Syndrome

Neurodynamic techniques (nerve gliding exercises) significantly reduce symptom severity and improve nerve conduction velocities. 2

These techniques promote median nerve gliding during upper limb movements and should be considered as first-line conservative management before surgical intervention. 2

Common Pitfalls

• Don't use venlafaxine in diabetic patients despite its efficacy for neuropathic pain—cardiovascular adverse events limit its use. 1
• Don't prescribe TCAs >100 mg/day due to cardiac death risk. 1
• Don't expect immediate improvement with oxaliplatin-induced neuropathy—warn patients about the coasting phenomenon. 1
• Don't overlook malignancy as a cause of numbness, particularly with isolated chin numbness (numb chin syndrome). 6